The Peritoneal Cancer Fund

Prof. dr. Wim CeelenIn addition to some unusual causes, metastasis on the peritoneum is also observed in around 7% of patients with colon cancer, 9% with pancreatic cancer, 14% with stomach cancer and 46% of those with ovarian cancer. Peritoneal cancer does not respond well to existing treatments, and patients risk developing serious symptoms.

But new methods of treatment are being developed now, in part thanks to the research of Professor Wim Ceelen at Ghent University. For example, there’s the PIPAC technique, where chemotherapy is sprayed into the abdominal cavity under pressure, during keyhole surgery. A first for Benelux. Because the chemotherapy barely enters the bloodstream, the treatment is less taxing for the patient. Moreover, this technique works in a far more targeted way.

Want to make a donation to the Peritoneal Cancer Fund?

Your donation to the Peritoneal Cancer Fund will go towards funding research into peritoneal cancer and the development of new treatments. A donation of €40 pays for one hour of scientific research into peritoneal cancer by Prof. Wim Ceelen’s research group. A donation of €1,200 can fund 30 hours of research. A donation of €15,000 covers the purchase of the materials needed for one year of research.

I make a donation

We gratefully welcome donations to the Peritoneal Cancer Fund - donations can be made via bank transfer to the account number BE26 3900 9658 0329, including the message “Fonds Buikvlieskanker".

“Because I got my life back.
Thanks to you, the team, and the donations made to the Peritoneal Cancer Fund.”
- W.V.X., Dutch patient of Prof. Wim Ceelen

More information about the fund?

Background information

The Ghent University Peritoneal Cancer Fund was set up in January 2016 on the initiative of a patient. The patient, who prefers to remain anonymous, set up the fund in order to give a boost to the groundbreaking research of Prof. Wim Ceelen and his research group.


The aim of the Fund is to encourage and support research into peritoneal cancer. Preclinical, translational, and clinical research are all eligible for support as long as they help further knowledge about the pathophysiology, molecular mechanisms, and treatment of peritoneal cancer (both primary and metastatic).

Want to find out more about the research?

What else can I do?

Contact us

Do you have questions about this or any of the other Ghent University funds?
Please get in touch and we will be happy to assist you.

University Fund of Ghent University
Wim Van der Planken
+32 9 264 33 84